Huawei and Qualcomm's patent licensing agreement was announced on October 5, 2026: the two companies have reached a broad, multi-year patent licence arrangement that includes cross-licences to their patent portfolios across 5G, computing, artificial intelligence and networking, together with Qualcomm's purchase of certain Huawei U.S. patents in computing, AI, networking and other fields. The transaction will close after the necessary regulatory approvals are received, and the announcement stresses that the arrangement follows fair, reasonable and non-discriminatory (FRAND) principles.
Why this marks a turning point in the relationship
This is Huawei's first patent licensing deal with Qualcomm that covers 5G technology, and the first under which Huawei licenses and assigns patents in computing, AI and networking to the U.S. chip designer. Licensing between the two goes back more than two decades: Huawei made its first licensing payment to Qualcomm in 2001 and received its first licensing income from Motorola in 2011. The roles have now shifted — Huawei has moved from mainly paying fees to being a patent holder whose portfolio Qualcomm buys into. Alan Fan, Huawei's Chief Intellectual Property Officer, pointed to Huawei's contributions to 4G/5G standards, including polar-code signal transmission technology approaching the physical limit; John Han, head of Qualcomm Technology Licensing, said the deal reaffirms industry recognition of Qualcomm's 5G leadership and its standard-essential patent licensing program.
What the $6.9 billion figure actually says
Huawei said the deal is expected to push the total value of its patent licensing agreements to more than $6.9 billion once completed, and that its intellectual property licensing business has generated positive revenue since 2021. The backdrop matters: U.S. trade restrictions since 2019 have limited Huawei's ability to buy advanced chips and crucial software, while the company kept raising R&D spending. Patent licensing has become one of the few channels that turn that research accumulation directly into cash flow. In August, Huawei announced a licensing deal with HP; the Qualcomm agreement is larger in scale and symbolism, showing that even without free access to chips, Huawei's stock of standard-essential patents still buys it a seat at the negotiating table.
The market impact will take time to show
Neither side disclosed the deal's price or royalty rates, so the real impact depends on regulatory approval, closing and execution. The more instructive angle for the industry is the precedent: when a company under export controls can still reach a cross-licence covering 5G and AI with a U.S. chip giant on the strength of its patent portfolio, patents stop being merely a legal department's defensive asset and become a business tool that can hedge supply-chain risk. Other holders of large standard-essential portfolios will have one more reference point when they sit down with major licensors.
